This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dey, D. C. Articles by Benjamin, T. L. Search for Related Content PubMed PubMed Citation Articles by Dey, D. C. Articles by Benjamin, T. L.

Accelerated Development of Polyoma Tumors and Embryonic Lethality: Different Effects of p53 Loss on Related Mouse Backgrounds¹

Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115

Abstract

Molecular evidence linking polyoma virus to p53 inactivation is thus far lacking, setting this highly oncogenic virus apart from other DNA tumor viruses. As a biological test for interaction, we studied the effects of p53 loss on development of virus-induced tumors. The absence of p53 led to more rapid tumor development on two different mouse backgrounds, indicating synergism between p53 loss and oncogenic pathways controlled directly by the virus. No effects of p53 on tumor type or frequency were noted. Polyoma tumor-derived cells in culture retained p53, and most of these showed induction of p21^CIP1/WAF1 in response to DNA damage. These results indicate that p53 functions are not directly and fully impaired by the virus in the intact host. On one mouse background, it was discovered that loss of p53 resulted in complete embryonic lethality prior to 11 days of gestation. This lethality could be rescued by inclusion of gene(s) from a 129/SvJ background.

This article has been cited by other articles:

				S. S. El-Dahr, K. Aboudehen, and Z. Saifudeen Transcriptional control of terminal nephron differentiation Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1273 - F1278. [Abstract] [Full Text] [PDF]

				J. Dahl, J. You, and T. L. Benjamin Induction and Utilization of an ATM Signaling Pathway by Polyomavirus J. Virol., October 15, 2005; 79(20): 13007 - 13017. [Abstract] [Full Text] [PDF]

				T. M. Love, R. de Jesus, J. A. Kean, Q. Sheng, A. Leger, and B. Schaffhausen Activation of CREB/ATF Sites by Polyomavirus Large T Antigen J. Virol., April 1, 2005; 79(7): 4180 - 4190. [Abstract] [Full Text] [PDF]

				D. Li, Y. Tian, Y. Ma, and T. Benjamin p150Sal2 Is a p53-Independent Regulator of p21WAF1/CIP Mol. Cell. Biol., May 1, 2004; 24(9): 3885 - 3893. [Abstract] [Full Text] [PDF]

				P. Velupillai, J. P. Carroll, and T. L. Benjamin Susceptibility to Polyomavirus-Induced Tumors in Inbred Mice: Role of Innate Immune Responses J. Virol., October 1, 2002; 76(19): 9657 - 9663. [Abstract] [Full Text] [PDF]

				D. Dey, J. Dahl, S. Cho, and T. L. Benjamin Induction and Bypass of p53 during Productive Infection by Polyomavirus J. Virol., September 15, 2002; 76(18): 9526 - 9532. [Abstract] [Full Text] [PDF]

				D. Li, K. Dower, Y. Ma, Y. Tian, and T. L. Benjamin A tumor host range selection procedure identifies p150sal2 as a target of polyoma virus large T antigen PNAS, December 4, 2001; 98(25): 14619 - 14624. [Abstract] [Full Text] [PDF]

				K. A. Gottlieb and L. P. Villarreal Natural Biology of Polyomavirus Middle T Antigen Microbiol. Mol. Biol. Rev., June 1, 2001; 65(2): 288 - 318. [Abstract] [Full Text] [PDF]

				S. Cho, Y. Tian, and T. L. Benjamin Binding of p300/CBP Co-activators by Polyoma Large T Antigen J. Biol. Chem., August 31, 2001; 276(36): 33533 - 33539. [Abstract] [Full Text] [PDF]